Johnson & Johnson在Galway扩大了中风治疗研发,促进了创新和就业。 Johnson & Johnson expands stroke treatment R&D in Galway, boosting innovation and jobs.

Johnson & Johnson Medtech通过其Cerenovus单元正在其Galway设施扩大神经血管研究与发展,重点是中风治疗、液体栓塞及相关条件。 Johnson & Johnson MedTech, via its Cerenovus unit, is expanding neurovascular R&D at its Galway facility, focusing on stroke treatments, liquid embolics, and related conditions. 这一增长加强了自2017年以来建立的现有工程、研发和制造能力。 The growth enhances existing engineering, R&D, and manufacturing capabilities established since 2017. 这一举动恰好与在加尔韦举行的第一次全球科学咨询委员会会议同时发生,会议强调了爱尔兰在医疗技术方面日益增强的作用。 The move coincides with the first global scientific advisory board meeting held in Galway, underscoring Ireland’s rising role in medical technology. 政府和工业领导人称赞这项投资推动了创新和高技能工作。 Government and industry leaders hailed the investment as a boost to innovation and high-skilled jobs.